TB-500 stimulates thymosin beta pathways, improves blood vessels formation, and boosts cell migration into injured areas
Importantly, BPC 157, but not PDGF-BB, stimulated earlier maturation of granulation tissue, soluble collagen concentration in the exudates (using sponge implantation), and organized collagen significantly more in wounds (i.e., on day 12 after daily treatment) (Tkalcevic et al., 2007)
Not for human consumption, clinical use, or any non-research applications
One focus: the companys strategy for peptide therapy
A workable protocol connects dose amount, dosing interval, study aim, compound handling, and the expected behavior of a short-acting signaling peptide